Glial cell line-derived neurotrophic factor reverses motor impairment in 16-17 month old rats

Neuroscience Letters

Volumn 211, Issue 2, 1996, Pages 81-84

  Bowenkamp, Kathryn E ^a   Lapchak, Paul A ^b   Hoffer, Barry J ^a   Bickford, Paula C ^a,c  

^a UNIVERSITY OF COLORADO   (United States)

^b AMGEN INC   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Aging; Dopamine; Glial cell line derived neurotrophic factor; Motor deficits; Neurotrophic factors; Striatum

Indexed keywords

DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; NEUROTROPHIC FACTOR;

ADOLESCENT; AGED; AGING; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DOSE RESPONSE; GLIA CELL; GRIP STRENGTH; LOCOMOTION; MOTOR COORDINATION; MOTOR DYSFUNCTION; MUSCLE STRENGTH; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030596531     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12729-4     Document Type: Article

References (24)

1. [1] Bickford, P.C., Heron, C., Young, D.A., Gerhardt, G.A. and De La Garza, R., Impaired acquisition of novel locomotor tasks in aged and norepinephrine-depleted F344 rats, Neurobiol. Aging, 13 (1992) 475-481.
2. [2] Bowenkamp, K.E., Hoffman, A.F., Gerhardt, G.A., Henry, M.A., Biddle, P.T., Hoffer, B.J. and Granholm, A.-C.E., Glial cell-line derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons, J. Comp, Neurol., 355 (1995) 479-489.
3. [3] Burwell, R.D., Lawler, C.P. and Gallagher, M., Mesostriatal dopamine markers in aged Long-Evans rats with sensorimotor impairment, Neurobiol. Aging, 16 (1995) 175-186.
4. [4] Campbell, B.A., Krauter, E.E. and Wallace, I.E., Animal models of aging: sensory motor and cognitive function in the aged rat. In D.G. Stein (Ed.), The Psychobiology of Aging: Problems and Perspectives, Elsevier/North-Holland, Amsterdam, 1980, pp. 201-226.
5. [5] Drucker-Colín, R. and García-Hernández, F., A new motor test sensitive to aging and dopaminergic function, J. Neurosci. Methods, 39 (1991) 153-161.
6. [6] Eriksdotter-Nilsson, M., Gerhardt, G., Seiger, A., Hoffer, B. and Granholm, A.-C., Multiple changes in noradrenergic mechanisms in the coeruleo-hippocampal pathway during aging. Structural and functional correlates in intraocular double grafts, Neurobiol. Aging, 10 (1989) 117-124.
7. [7] Felten, D.L., Felten, S.Y., Fuller, R.W., Romano, T.D., Smalstig, E.B., Wong, D.T. and Clemens, J.A., Chronic dietary pergolide preserves nigrostriatal neuronal integrity in aged-Fischer-344 rats, Neurobiol. Aging, 13 (1992) 339-351.
8. [8] Friedemann, M.N. and Gerhardt, G.A., Regional effects of aging on dopaminergic function in the Fischer-344 rat, Neurobiol. Aging, 13 (1992) 325-332.
9. [9] Gage, F.H., Dunnet, S.B., Stenevi, U. and Björklund, A., Recovery of motor impairments by intrastriatal nigra grafts, Science, 221 (1983) 966-969.
10. 2 receptor activation in aged F344 rats, personal communication.
11. 3H] spiroperidol binding in rat striatum during ageing. J. Pharm. Pharmacol., 30 (1978) 448-449.
12. [12] Henry, J.M., Filburn, C.R., Joseph, J.A. and Roth, G.S., Effect of aging on striatal dopamine receptor types in Wistar rats, Neurbiol. Aging, 7 (1986) 357-361.
13. [13] Hoffer, B.J., Hoffman, A., Bowenkamp, K., Huettl, P., Hudson, J., Martin, D., Lin, L.-F. and Gerhardt, G.A., Glial cell-line derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo, Neurosci. Lett., 182 (1994) 107-111.
14. [14] Hudson, J., Granholm, A.-C., Gerhardt, G.A., Henry, M.A., Hoffman, A., Biddle, P., Leela, N.S., Mackerlova, L., Lile, J., Collins, F. and Hoffer, B.J., Glial cell-line derived neurotrophic factor augments midbrain dopaminergic circuits in vivo, Brain Res. Bull., 36 (1995) 425-432.
15. [15] Joseph, J.A. and Roth, G.S., Altered striatal dopaminergie and cholinergic reciprocal inhibitory control and motor behavioral decrements in senescence, Ann. N.Y. Acad. Sci., 521 (1988) 110-122.
16. [16] Joyce, J.N., Loeschen, S.K., Sapp, D. and Marshall, J.F., Age-related regional loss of caudate-putamen dopamine receptors revealed by quantitative autoradiography, Brain Res., 378 (1986) 158-163.
17. [17] Kearns, C.M. and Gash, D.M., GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo, Brain Res., 672 (1995) 104-111.
18. [18] Lin, L.-F., Dohery D.H., Lile, J.D., Bektesh, S. and Collins, F., GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons, Science, 260 (1993) 1130-1132.
19. [19] Marshall, J.F. and Berrios, N., Movement disorders of aged rats: reversal by dopamine receptor stimulation, Science, 206 (1979) 477-479.
20. [20] Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1986, 128 pp.
21. [21] Pellegrino, L.J. and Altman, J., Effects of differential interference with postnatal cerebellar neurogenesis on motor performance, activity level, and maze learning of rats: a developmental study, J. Comp. Physiol. Psychol., 93 (1979) 1-33.
22. [22] Severson, J.A., Marcussdon, J., Winbland, B. and Finsch, C.E., Age-correlated loss of dopaminergic sites in human basal ganglia, J. Neurochem., 39 (1982) 1623-1632.
23. [23] Springer, J.E., Mu, X., Bergmann, L.W. and Trojanoqski, J.Q., Expression of GDNF in rat and human nervous tissues, Exp. Neurol., 127 (1994) 167-170.
24. [24] Wallace, J.E., Krauter, E. and Campbell, B.A., Motor and reflexive behavior in the aging rat, J. Gerontol., 35 (1980) 364-370.